{"organizations": [], "uuid": "6bbcb3e5b3e36c17be4a2656054f8115dd2daaf6", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s3.reutersmedia.net/resources/r/?d=20180124&i=RCV004EOL&w=1200&r=RCV004EOL&t=2", "site_section": "http://feeds.reuters.com/reuters/USVideoLatest\r", "section_title": "Reuters Video: Latest Videos US", "url": "https://www.reuters.com/video/2018/01/24/pharma-firms-need-to-do-more-to-counter?videoId=388309670", "country": "US", "domain_rank": 408, "title": "Pharma firms 'need to do more' to counter superbugs", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-24T07:39:00.000+02:00", "replies_count": 0, "uuid": "6bbcb3e5b3e36c17be4a2656054f8115dd2daaf6"}, "author": "", "url": "https://www.reuters.com/video/2018/01/24/pharma-firms-need-to-do-more-to-counter?videoId=388309670", "ord_in_thread": 0, "title": "Pharma firms 'need to do more' to counter superbugs", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Pharma firms 'need to do more' to counter superbugs 12:32am EST - 02:01 \nDrugmakers' response to the threat posed by ''superbugs'' remains patchy even after years of warnings, according to the first analysis of individual companies' efforts to tackle the antibiotic resistance crisis.   \nDrugmakers' response to the threat posed by \"superbugs\" remains patchy even after years of warnings, according to the first analysis of individual companies' efforts to tackle the antibiotic resistance crisis.  //reut.rs/2n6MIU9", "external_links": [], "published": "2018-01-24T07:39:00.000+02:00", "crawled": "2018-01-24T08:11:46.002+02:00", "highlightTitle": ""}